Skip to main content Help with accessibility Skip to main navigation

FOSTAMATINIB tablets (Tavlesse®▼) for treating refractory chronic immune thrombocytopenia

CCG Approval Status:

Date Added: 24 - Nov - 2022
Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of FOSTAMATINIB tablets (Tavlesse®▼), by specialists only, for treating refractory chronic immune thrombocytopenia in accordance with NICE TA835.

NHS Cheshire and Merseyside APPROVED